H.R. 10717 aims to amend the U.S. Code to ensure that TRICARE beneficiaries, specifically those suffering from alopecia (including cases caused by chemotherapy), are provided with wigs as part of their healthcare benefits.
H.R. 10717 was introduced in the 119th Congress by Eugene Vindman (Democrat) and is currently listed as “Introduced”. It is classified under the Armed Forces and National Security policy area, one of 305 bills in that area we track this Congress.
Eugene Vindman is the sponsor of 17 bills in our database this Congress, so H.R. 10717 is part of a broader legislative agenda rather than a one-off proposal.
Our conflict-of-interest analysis rates H.R. 10717 2/10 (low risk), higher than 76% of analyzed bills; the average in Armed Forces and National Security is 2.1/10.
Supporters of H.R. 10717 have praised the bill for recognizing the emotional and psychological impact of hair loss due to medical conditions. Advocates highlight that providing wigs can significantly improve the quality of life for individuals undergoing treatment and dealing with alopecia.
Critics of H.R. 10717 argue that expanding benefits to include wigs may place additional financial burdens on the TRICARE system. Some express concerns about prioritizing cosmetic items over other critical healthcare needs, suggesting that resources could be better allocated elsewhere.
The analysis of H.R. 10717, which aims to provide wigs to TRICARE beneficiaries with alopecia, reveals no direct industry overlaps between the bill's subject matter and the sponsor Eugene Vindman's top donor industries. Vindman's top donors include Health Professionals, contributing $120,000,000, and Retired individuals, contributing $37,500,000. While the Health Professionals sector may have indirect interests in healthcare-related legislation, there is no specific financial incentive linked to the provision of wigs for alopecia treatment. The absence of PAC contributions further reduces the potential for conflicts of interest. Voters should be aware that while large donations exist, they do not directly correlate with the bill's provisions, indicating a low risk of conflict.
Top industries funding Eugene Vindman, ranked by total contributions.
Source: OpenSecrets.org (Center for Responsive Politics)
What does H.R. 10717 do?
H.R. 10717 aims to amend the U.S. Code to ensure that TRICARE beneficiaries, specifically those suffering from alopecia (including cases caused by chemotherapy), are provided with wigs as part of their healthcare benefits.
Has H.R. 10717 received a floor vote?
No roll-call vote on H.R. 10717 is recorded in our database yet. Its current status is “Introduced”.
Does H.R. 10717 have a conflict of interest?
Our conflict-of-interest analysis rates H.R. 10717 2/10 (low risk), higher than 76% of analyzed bills; the average in Armed Forces and National Security is 2.1/10. This score reflects overlap between the sponsor’s campaign funding, lobbying activity, and the industries the bill affects. It is a transparency indicator, not an accusation.
What is the status of H.R. 10717?
H.R. 10717 is currently “Introduced” as of our last update on October 6, 2026.
Who sponsored H.R. 10717?
H.R. 10717 was sponsored by Eugene Vindman (Democrat).
